L41.0 Pityriasis lichenoides et varioliformis acuta

Name of the Condition

• Pityriasis lichenoides et varioliformis acuta

Summary

Pityriasis lichenoides et varioliformis acuta (PLEVA) is a rare, self-limiting skin condition characterized by the sudden onset of red, scaly, and sometimes ulcerated papules. It is part of the pityriasis lichenoides spectrum, which includes chronic forms. PLEVA typically presents with widespread, discrete lesions that may resemble chickenpox or other viral exanthems. The condition is generally benign but can cause discomfort and temporary scarring.

Causes

The exact cause of PLEVA remains unclear, but it is thought to involve an abnormal immune response, possibly triggered by infections (such as viral or bacterial agents) or medications. Some theories suggest a hypersensitivity reaction, though no definitive infectious or environmental trigger has been consistently identified. The condition is not contagious.

Risk Factors

• Age: Most commonly affects children and young adults, though it can occur at any age.
• Immune system: Individuals with altered immune responses may be more susceptible.
• Prior infections: A history of viral or bacterial infections has been reported in some cases.
• Medications: Rarely, certain drugs may trigger or exacerbate the condition.

Symptoms

• Sudden appearance of red, raised papules or plaques.
• Scaling, crusting, or ulceration of lesions.
• Lesions may be widespread or localized, often on the trunk, arms, or legs.
• Mild itching or burning sensation.
• Fever or malaise in severe cases.

Diagnosis

Diagnosis is primarily clinical, based on the appearance of lesions and patient history. A skin biopsy may be performed to confirm the diagnosis, showing characteristic histological features such as lymphocytic infiltration and epidermal necrosis. Laboratory tests are typically not required unless other conditions are suspected.

Treatment Options

• Topical Therapies: Corticosteroid creams or calcipotriene may reduce inflammation and scaling.
• Phototherapy: Ultraviolet light (UVB or PUVA) can help clear lesions in some cases.
• Oral Medications: Antibiotics (e.g., tetracyclines) or immunosuppressants may be used for severe or persistent cases.
• Supportive Care: Moisturizers and gentle skin care to manage discomfort.

Prognosis and Follow-Up

PLEVA is usually self-limiting, with lesions resolving over weeks to months. Recurrences are possible, and some cases may progress to the chronic form (pityriasis lichenoides chronica). Follow-up is recommended to monitor for resolution or complications, especially if symptoms persist or worsen.

Complications

• Scarring or hyperpigmentation at lesion sites.
• Secondary bacterial infection from ulcerated lesions.
• Rarely, progression to lymphoma (though this is controversial and not well-established).

Lifestyle & Prevention

• Avoid known triggers (e.g., certain medications or infections) if identified.
• Use gentle skin care to prevent irritation.
• Protect skin from excessive sun exposure, as UV light may exacerbate symptoms.
• Maintain good hygiene to reduce infection risk.

When to Seek Professional Help

• If lesions are severe, widespread, or painful.
• If fever, malaise, or systemic symptoms develop.
• If lesions do not improve with initial treatment or worsen over time.
• If signs of secondary infection (e.g., pus, increased redness) are present.

Tips for Medical Coders

When coding for Pityriasis lichenoides et varioliformis acuta (ICD-10-CM code L41.0), ensure documentation supports the acute, varioliform presentation. Note the presence of papules, scaling, or ulceration, and confirm the absence of chronicity or progression to other forms. Accurate coding requires clear clinical correlation with the acute nature of the condition.